Package 68462-652-01

{"route": ["ORAL"], "spl_id": "a586519f-97a3-4a3a-951a-c3ecaab95334", "openfda": {"upc": ["0368462651018", "0368462649015", "0368462652015", "0368462647011", "0368462653012"], "unii": ["6DPV8NK46S", "G83415V073", "JJ768O327N", "H527KAP6L5"], "rxcui": ["541363", "541878", "541892", "577957", "577961"], "spl_set_id": ["4564e404-8d71-4585-ab78-55857f477143"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68462-652-01)", "package_ndc": "68462-652-01", "marketing_start_date": "20250512"}], "brand_name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate", "product_id": "68462-652_a586519f-97a3-4a3a-951a-c3ecaab95334", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]", "Central Nervous System Stimulation [PE]"], "product_ndc": "68462-652", "dea_schedule": "CII", "generic_name": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate", "labeler_name": "GLENMARK PHARMACEUTICALS INC., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate", "active_ingredients": [{"name": "AMPHETAMINE DL-ASPARTATE", "strength": "5 mg/1"}, {"name": "AMPHETAMINE SULFATE", "strength": "5 mg/1"}, {"name": "DEXTROAMPHETAMINE SACCHARATE", "strength": "5 mg/1"}, {"name": "DEXTROAMPHETAMINE SULFATE", "strength": "5 mg/1"}], "application_number": "ANDA210754", "marketing_category": "ANDA", "marketing_start_date": "20250512", "listing_expiration_date": "20271231"}